ClinicalTrials HQ

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

Recruiting · NCT06975293 · Registry updated 2026-10-07
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected SarcomasNeoplasms by Histologic Type, Neoplasms, Adipose Tissue, Neoplasms, Connective and Soft Tissue, leiomyosarcoma, liposarcoma, myomatous neoplasm, neoplasm, sarcomaRecruitingPhase 1 / Phase 22026-10-07NCT06975293

2 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Coherus Oncology, Inc.14
STORM Therapeutics LTD1

14 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Dana Farber Cancer InstituteBostonUnited States300
Fred Hutchinson Cancer CenterSeattleUnited States250
MD Anderson Cancer CenterHoustonUnited States589
Memorial Sloan Kettering Cancer CenterNew YorkUnited States1000
NEXT DallasIrvingUnited States18
NEXT HoustonHoustonUnited States11
NEXT OncologySan AntonioUnited States70
NEXT OncologyFairfaxUnited States31
Northwell Health Cancer InstituteLake SuccessUnited States11
START MidwestGrand RapidsUnited States79
The START CenterSan AntonioUnited States2
University Hospitals Cleveland Medical CenterClevelandUnited States234
University of California, San FranciscoSan FranciscoUnited States72
University of Miami-Sylvester Comprehensive Cancer CenterMiamiUnited States1